论文部分内容阅读
CTLA4-Ig高度相关的变异体Belatacept作为一种新型高选择、特异性的免疫抑制剂近年来受到人们的高度关注。本文就Belatacept的相关研究进展作一简要介绍。
Belatacept, a highly-relevant variant of CTLA4-Ig, has attracted much attention in recent years as a new, highly selective and specific immunosuppressant. This article gives a brief introduction of Belatacept related research progress.